|本期目录/Table of Contents|

[1]许昊男,王小敏,刘姝婷,等.养胃颗粒治疗慢性萎缩性胃炎作用机制的网络药理学研究[J].医学研究与战创伤救治(原医学研究生学报),2025,38(01):79-86.[doi:10.16571/j.cnki.2097-2768.2025.01.013]
　XU Haonan,WANG Xiaomin,LIU Shuting,et al.Research on mechanism of Yangwei granules in treating chronic atrophic gastritis based on network pharmacology[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2025,38(01):79-86.[doi:10.16571/j.cnki.2097-2768.2025.01.013]
点击复制

养胃颗粒治疗慢性萎缩性胃炎作用机制的网络药理学研究()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
38卷
期数:
2025年01期
页码:
79-86
栏目:
论著·药学研究
出版日期:
2025-01-20

文章信息/Info

Title:
Research on mechanism of Yangwei granules in treating chronic atrophic gastritis based on network pharmacology
文章编号:
2097-2768（2025）01-0079-08
作者:
许昊男; 王小敏; 刘姝婷; 许蕾
作者单位：210029 南京，江苏省人民医院药学部（许昊男）；210002 南京，东部战区总医院第五派驻门诊部（王小敏、刘姝婷、许蕾）
Author(s):
XU Haonan; WANG Xiaomin; LIU Shuting; XU Lei
（1.Department of Pharmacy，Jiangsu Province Hospital，Nanjing 210029，Jiangsu，China；2.The Fifth Stationed Out?patient Department，General Hospital of Eastern Theater Command，PLA，Nanjing 210002，Jiangsu，China）
关键词:
养胃颗粒; 慢性萎缩性胃炎; 网络药理学; 分子对接; 作用机制
Keywords:
Yangwei granules; chronic atrophic gastritis; network pharmacology; molecular docking; mechanism
分类号:
R573.3
DOI:
10.16571/j.cnki.2097-2768.2025.01.013
文献标志码:
A
摘要:
目的 探讨养胃颗粒治疗慢性萎缩性胃炎（CAG）的潜在活性成分和作用机制。方法通过中药系统药理学分析平台（TCMSP）检索养胃颗粒的潜在活性成分和作用靶点，通过GeneCards、TTD数据库获取CAG相关疾病靶点，将共同靶点与潜在活性成分导入Cytoscape 3.10.1 软件构建中药-成分-共同靶点-CAG相互作用网络，通过String 11.0 数据库获得共同靶点蛋白相互作用网络及核心靶点；通过David 数据库进行基因本体论（GO）功能富集和京都基因与基因组百科全书（KEGG）通路富集分析。运用Autodock vina 软件对度值排名前五的潜在活性成分及靶点进行分子对接验证。结果筛选获得养胃颗粒137个潜在活性成分，CAG与2765个靶点相关，潜在活性成分与CAG有170个共同靶点。核心成分包括槲皮素、木犀草素、山柰酚等，核心靶点包括IL-6、TNF、TP53等。KEGG富集分析主要涉及癌症的发病途径、AGE-RAGE信号通路在糖尿病并发症中的作用等。分子对接结果显示，度值前五的成分与靶点具有较好的结合活性。结论养胃颗粒治疗CAG的主要机制可能通过槲皮素等核心成分作用于IL-6等靶点发挥作用，为深入阐明养胃颗粒的药效物质基础及作用机制提供参考。
Abstract:
Objective To investigate the potential active ingredients and mechanism of Yangwei granules in treating chronicatrophic gastritis（CAG）. Methods The potential active components and targets of Yangwei granules were searched by the Tradi?tional Chinese Medicine Systems Pharmacology Database and Analysis Platform（TCMSP），and CAG related disease targets were ob?tained by GeneCards and TTD databases. The common target and potential active ingredients were imported into Cytoscape 3.10.1 soft?ware to construct the TCM-component-common target -CAG interaction network，and the common target protein interaction network andcore targets were obtained through String 11.0 database. Genetic ontological（GO）functional enrichment and Kyoto Encyclopedia ofGenes and Genomes（KEGG）pathway enrichment analysis were performed using the David database. Autodock vina software was usedto verify the molecular docking of the top five potential active components and targets. Results 137 potential active components ofYangwei granules were selected. CAG was associated with 2765 tar?gets，and there were 170 common targets between CAG and CAG.Core components included quercetin，luteolin，kaempferol，etc. Coretargets included IL - 6，TNF，TP53，etc. KEGG enrichment analysismainly involved the pathogenesis of cancer and the role of AGERAGEsignaling pathway in diabetic complications. The results of mo?lecular docking showed that the top five components had better bind?ing activity with the target. Conclusion The main mechanism of Yangwei granules in the treatment of CAG may be through the action of quercetin and other core components on IL-6 and other targets，which provides a reference for further elucidating the pharmacodynamic material basis and mechanism of Yangwei granules.

参考文献/References:

［1］ Bray F，Ferlay J，Soerjomataram I，et al.Global cancer statistics2018: GLOBOCAN estimates of incidence and mortality world?wide for 36 cancers in 185 countries［J］.CA Cancer J Clin，201868（6）:394-424.［2］ Weng J，Wu XF，Shao P，et al.Medicine for chronic atrophic gas?tritis: a systematic review，meta-and network pharmacology anal?ysis［J］.Ann Med，2023，55（2）:2299352.［3］ 李军祥，陈誩，吕宾，等.慢性萎缩性胃炎中西医结合诊疗共识意见（2017年）［J］.中国中西医结合消化杂志，2018，26（2）:121-131.［4］ Yin Y，Liang H，Wei N，et al.Prevalence of chronic atrophic gas?tritis worldwide from 2010 to 2020: an updated systematic reviewand meta-analysis［J］. Ann Palliat Med，2022，11（12）: 3697-3703.［5］ Yang H，Yang WJ，Hu B.Gastric epithelial histology and precan?cerous conditions［J］.World J Gastrointest Oncol，2022，14（2）:396-412.［6］ Ma X，Zhang Z，Qin X，et al.Therapeutic Effect of Curcumol onChronic Atrophic Gastritis （CAG） and Gastric Cancer IsAchieved by Downregulating SDF-1α/CXCR4/VEGF Expression［J］.J Oncol，2022，2022:3919053.［7］ 周玲，唐梅文，刘文健，等.基于网络药理学和分子对接技术探讨七方胃痛颗粒治疗慢性萎缩性胃炎的作用机制［J］.实用中医内科杂志，2024，38（9）:67-72，157-159.［8］ Chen X，Shen K，Deng Y，et al.A Randomized Double-blind Clin?ical Trial of Weierkang Pills for the Treatment of Chronic Atro?phic Gastritis［J］.J Clin Gastroenterol，2023，57（2）:165-171.［9］ Wang L，Ding X，Li P，et al.Efficacy and safety of Weifuchun tab?let for chronic atrophic gastritis: A systematic review and metaanalysis［J］.PLoS One，2023，18（4）:e0284411.［10］ 周本刚，梅宇宙，颜学良，等.养胃颗粒治疗慢性胃炎有效性和安全性的系统评价与Meta分析［J］.中国中药杂志，2020，45（20）:5008-5016.［11］ 丁文，危贵君，胡奕.养胃颗粒治疗慢性萎缩性胃炎临床研究［J］.新中医，2019，51（7）:136-138.［12］ Hopkins AL.Network pharmacology: the next paradigm in drugdiscovery［J］.Nat Chem Biol，2008，4（11）:682-690.［13］ Shang L，Wang Y，Li J，et al.Mechanism of Sijunzi Decoction inthe treatment of colorectal cancer based on network pharmacolo?gy and experimental validation［J］.J Ethnopharmacol，2023，302（Pt A）:115876.［14］ Zhao N，Kong H，Liu H，et al.A network pharmacology approachto evaluate the synergistic effect of dihydromyricetin and myrici?trin in vine tea on the proliferation of B16F10 cells［J］.Front Nu?tr，2022，9:993133.［15］ Xu L，Zhang Y，Zhang P，et al.Integrated Metabolomics and Net?work Pharmacology Strategy-Driven Active Traditional ChineseMedicine Ingredients Discovery for the Alleviation of CisplatinNephrotoxicity［J］.Chem Res Toxicol，2019，32（12）:2411-2421.［16］ 宋亚南，王云，张村，等.基于特征图谱-网络药理学-多指标定量的辣木叶调血脂质量标志物（Q-Marker）研究［J］.中草药，2024，55（5）:1686-1698.［17］ Wang SY，Zhou SW，Yu B.Exploring the mechanism of Mie-youdecoction“homotherapy for heteropathy”to chronic atrophic gas?tritis and gastric ulcer using network pharmacology-moleculardocking［J］.J Chin Pharm Sci，2024，33（3）:258-271.［18］ Nie K，Zheng Z，Li X，et al.Explore the active ingredients and po?tential mechanisms of JianPi QingRe HuaYu Methods in thetreatment of gastric inflammation-cancer transformation by net?work pharmacology and experimental validation［J］.BMC Com?plement Med Ther，2023，23（1）:411.［19］ Hsieh HL，Yu MC，Cheng LC，et al.Quercetin exerts anti-inflam?matory effects via inhibiting tumor necrosis factor-α-induced ma?trix metalloproteinase-9 expression in normal human gastric epi?thelial cells［J］.World J Gastroenterol，2022，28（11）:1139-1158.［20］ Zhang JY，Lin MT，Zhou MJ，et al.Combinational Treatment ofCurcumin and Quercetin against Gastric Cancer MGC-803 Cellsin Vitro［J］.Molecules，2015，20（6）:11524-11534.［21］ Lei CS，Hou YC，Pai MH，et al.Effects of quercetin combinedwith anticancer drugs on metastasis-associated factors of gastriccancer cells: in vitro and in vivo studies［J］.J Nutr Biochem，2018，51:105-113.［22］ Tu W，Hong Y，Huang M，et al.Effect of kaempferol on hedgehogsignaling pathway in rats with chronic atrophic gastritis-Based onnetwork pharmacological screening and experimental verification［J］.Biomed Pharmacother，2022，145:112451.［23］ Kim SH，Park JG，Sung GH，et al.Kaempferol，a dietary flavo?noid，ameliorates acute inflammatory and nociceptive symptomsin gastritis，pancreatitis，and abdominal pain［J］.Mol Nutr FoodRes，2015，59（7）:1400-1405.［24］ Min YS，Bai KL，Yim SH，et al.The effect of luteolin-7-O-beta-Dglucuronopyranosideon gastritis and esophagitis in rats［J］.ArchPharm Res，2006，29（6）:484-489.［25］ Zhou S，Duan Y，Deng Y，et al.Study on the Mechanism of Lian?pu Drink for the Treatment of Chronic Gastritis Based on Net?work Pharmacology［J］.Evid Based Complement Alternat Med，2021，2021:6693472.［26］ Shi XF，Yu Q，Wang KB，et al.Active ingredients Isorhamnetinof Croci Srigma inhibit stomach adenocarcinomas progression byMAPK / mTOR signaling pathway［J］. Sci Rep，2023，13（1）:12607.［27］ 许昊男，王兆耀，吴慧敏，等.蓝芩口服液治疗上呼吸道感染作用机制网络药理学研究［J］.中国药业，2023，32（16）:40-47.［28］ 马子涵，贾西云，徐倩，等.胃癌组织中AKT1与STMN1表达的关系及其临床意义［J］.肿瘤基础与临床，2019，32（6）:471-474.［29］ 蒋欣琪，卢涛，罗志强，等.基于网络药理学及分子对接的胃复春片治疗慢性萎缩性胃炎机制探讨及体外细胞实验验证［J］.药物评价研究，2022，45（10）:1959-1971.［30］ 于春月，李依聪，苏泽琦，等.慢痞消对慢性萎缩性胃炎大鼠血清炎症指标IL-1β、IL-6和TNF-α表达水平的影响［J］.中华中医药杂志，2019，34（5）:1979-1983.［31］ 罗楠，李萌，夏晨曦，等.基于网络药理学的健脾通络解毒方治疗慢性萎缩性胃炎作用机制研究［J］.中国医院用药评价与分析，2023，23（10）:1156-1162.［32］ 刘璇，耿乐，冯小可，等.猪苓多糖对Hp诱导胃黏膜上皮细胞炎症的保护作用［J］.医学研究生学报，2022，35（6）:568-574.［33］ Chen G，Tang N，Wang C，et al.TNF-α-inducing protein of Heli?cobacter pylori induces epithelial-mesenchymal transition（EMT）in gastric cancer cells through activation of IL-6/STAT3signaling pathway［J］.Biochem Biophys Res Commun，2017，484（2）:311-317.［34］ Shiao YH，Rugge M，Correa P，et al.p53 alteration in gastric pre?cancerous lesions［J］.Am J Pathol，1994，144（3）:511-517.［35］ Fenoglio-Preiser CM，Wang J，Stemmermann GN，et al.TP53 andgastric carcinoma: a review［J］.Hum Mutat，2003，21（3）:258-270.［36］ Murakami K，Fujioka T，Okimoto T，et al.Analysis of p53 genemutations in Helicobacter pylori-associated gastritis mucosa inendoscopic biopsy specimens［J］.Scand J Gastroenterol，1999，34（5）:474-477.［37］ 高尤亮，黄铭涵，方文怡，等.健脾清化散瘀饮对脾虚湿热血瘀证慢性萎缩性胃炎黏膜TNF-α、p53、Ki-67表达的影响［J］.中国中西医结合消化杂志，2020，28（8）:590-594.［38］ 张玲梅，张万方.糖尿病并发亚临床型胃肠病的机制探讨［J］.山西医科大学学报，2003，34（4）:372-373.［39］ Shen CY，Lu CH，Wu CH，et al.The Development of Maillard Re?action，and Advanced Glycation End Product（AGE）- Receptorfor AGE （RAGE） Signaling Inhibitors as Novel TherapeuticStrategies for Patients with AGE-Related Diseases［J］. Mole?cules，2020，25（23）:5591.［40］ 邢佳宝，李生隆，达娃卓玛，等.基于数据挖掘、网络药理学技术探讨藏药治疗慢性萎缩性胃炎的用药规律及作用机制［J］.吉林医药学院学报，2024，45（2）:90-96.［41］ Yang S，Zhang J，Yan Y，et al. Network Pharmacology-BasedStrategy to Investigate the Pharmacologic Mechanisms of Atracty?lodes macrocephala Koidz.for the Treatment of Chronic Gastritis［J］.Front Pharmacol，2020，10:1629.［42］ Della Bella C，D?Elios S，Coletta S，et al.Increased IL-17A Se?rum Levels and Gastric Th17 Cells in Helicobacter pylori-Infect?ed Patients with Gastric Premalignant Lesions［J］.Cancers（Ba?sel），2023，15（6）:1662.［43］ Ghazi HF，Mustafa M，Fahad HM.Interleukin-17agene Polymor?phism，Serum Level and Its Tissue Expression in Iraqi PatientsGastric Lesions［J］.Med Arch，2021，75（1）:23-26.［44］ Tong Y，Zhao X，Wang R，et al.Therapeutic effect of berberineon chronic atrophic gastritis based on plasma and urine metabo?lisms［J］.Eur J Pharmacol，2021，908:174335.

相似文献/References:

[1]舒荣文,黄先华.慢性萎缩性胃炎中西医治疗的近况[J].医学研究与战创伤救治(原医学研究生学报),2013,15(04):388.[doi:10.3969/j.issn.1672-271X.2013.04.022]

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（81802557）；江苏省研究型医院学会精益化用药- 石药专项科研基金（JY202137）
更新日期/Last Update: 2025-01-20